Selected research
Industry Growth & Trends
Global Gene Synthesis Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Gene Synthesis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Synthesis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Gene Synthesis Software market include Eurofins Genomics, ATUM, Biotage, Bioneer Corporation, Eurogentec, GenScript, GENEWIZ, Integrated DNA Technologies and OriGene Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gene Synthesis Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gene Synthesis Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Synthesis Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Synthesis Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Gene Synthesis Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gene Synthesis Software Market by Company
Eurofins Genomics
ATUM
Biotage
Bioneer Corporation
Eurogentec
GenScript
GENEWIZ
Integrated DNA Technologies
OriGene Technologies
Thermo Fisher Scientific
Bio Basic
Twist Bioscience
BioCat GmbH
ProteoGenix
Charles River
Biosearch Technologies
Beijing SBS Genetech
Eton Bioscience
Gene Synthesis Software Segment by Type
Solid Phase Synthesis
Chip-based DNA Synthesis
PCR-based Enzyme Synthesis
Gene Synthesis Software Segment by Application
Academic and Research Institutes
Biotech and Pharmaceutical
Diagnostic Laboratories
Others
Gene Synthesis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Gene Synthesis Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Phase Synthesis
- Chip-based DNA Synthesis
- PCR-based Enzyme Synthesis
Applications
- Academic and Research Institutes
- Biotech and Pharmaceutical
- Diagnostic Laboratories
- Others
Companies covered
- Eurofins Genomics
- ATUM
- Biotage
- Bioneer Corporation
- Eurogentec
- GenScript
- GENEWIZ
- Integrated DNA Technologies
- OriGene Technologies
- Thermo Fisher Scientific
- Bio Basic
- Twist Bioscience
- BioCat GmbH
- ProteoGenix
- Charles River
- Biosearch Technologies
- Beijing SBS Genetech
- Eton Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Gene Synthesis Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Gene Synthesis Software Market Size by Region (2021-2032)
- 1.4.1 Global Gene Synthesis Software Market Size by Region (2021-2026)
- 1.4.2 Global Gene Synthesis Software Market Size by Region (2027-2032)
- 1.5 Key Regions Gene Synthesis Software Market Size (2021-2032)
- 1.5.1 North America Gene Synthesis Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Gene Synthesis Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Gene Synthesis Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Gene Synthesis Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Gene Synthesis Software Market Size Growth Rate (2021-2032)
2 Gene Synthesis Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Solid Phase Synthesis
- 2.1.2 Chip-based DNA Synthesis
- 2.1.3 PCR-based Enzyme Synthesis
- 2.2 Global Gene Synthesis Software Market Size by Type
- 2.2.1 Global Gene Synthesis Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Gene Synthesis Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Gene Synthesis Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Gene Synthesis Software Market Size by Regions
- 2.3.1 North America Gene Synthesis Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Gene Synthesis Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Gene Synthesis Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Gene Synthesis Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Gene Synthesis Software Market Size Breakdown by Type (2021-2026)
3 Gene Synthesis Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Academic and Research Institutes
- 3.1.2 Biotech and Pharmaceutical
- 3.1.3 Diagnostic Laboratories
- 3.1.4 Others
- 3.2 Global Gene Synthesis Software Market Size by Application
- 3.2.1 Global Gene Synthesis Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Gene Synthesis Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Gene Synthesis Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Gene Synthesis Software Market Size by Regions
- 3.3.1 North America Gene Synthesis Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Gene Synthesis Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Gene Synthesis Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Gene Synthesis Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Gene Synthesis Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Gene Synthesis Software Industry Trends
- 4.2 Gene Synthesis Software Industry Drivers
- 4.3 Gene Synthesis Software Industry Opportunities and Challenges
- 4.4 Gene Synthesis Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Gene Synthesis Software Revenue (2021-2026)
- 5.2 Global Gene Synthesis Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Gene Synthesis Software Key Company Headquarters & Area Served
- 5.4 Global Gene Synthesis Software Company, Product Type & Application
- 5.5 Global Gene Synthesis Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Gene Synthesis Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Gene Synthesis Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Gene Synthesis Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eurofins Genomics
- 6.1.1 Eurofins Genomics Company Information
- 6.1.2 Eurofins Genomics Business Overview
- 6.1.3 Eurofins Genomics Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eurofins Genomics Gene Synthesis Software Product Portfolio
- 6.1.5 Eurofins Genomics Recent Developments
- 6.2 ATUM
- 6.2.1 ATUM Company Information
- 6.2.2 ATUM Business Overview
- 6.2.3 ATUM Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 ATUM Gene Synthesis Software Product Portfolio
- 6.2.5 ATUM Recent Developments
- 6.3 Biotage
- 6.3.1 Biotage Company Information
- 6.3.2 Biotage Business Overview
- 6.3.3 Biotage Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Biotage Gene Synthesis Software Product Portfolio
- 6.3.5 Biotage Recent Developments
- 6.4 Bioneer Corporation
- 6.4.1 Bioneer Corporation Company Information
- 6.4.2 Bioneer Corporation Business Overview
- 6.4.3 Bioneer Corporation Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bioneer Corporation Gene Synthesis Software Product Portfolio
- 6.4.5 Bioneer Corporation Recent Developments
- 6.5 Eurogentec
- 6.5.1 Eurogentec Company Information
- 6.5.2 Eurogentec Business Overview
- 6.5.3 Eurogentec Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eurogentec Gene Synthesis Software Product Portfolio
- 6.5.5 Eurogentec Recent Developments
- 6.6 GenScript
- 6.6.1 GenScript Company Information
- 6.6.2 GenScript Business Overview
- 6.6.3 GenScript Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GenScript Gene Synthesis Software Product Portfolio
- 6.6.5 GenScript Recent Developments
- 6.7 GENEWIZ
- 6.7.1 GENEWIZ Company Information
- 6.7.2 GENEWIZ Business Overview
- 6.7.3 GENEWIZ Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GENEWIZ Gene Synthesis Software Product Portfolio
- 6.7.5 GENEWIZ Recent Developments
- 6.8 Integrated DNA Technologies
- 6.8.1 Integrated DNA Technologies Company Information
- 6.8.2 Integrated DNA Technologies Business Overview
- 6.8.3 Integrated DNA Technologies Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Integrated DNA Technologies Gene Synthesis Software Product Portfolio
- 6.8.5 Integrated DNA Technologies Recent Developments
- 6.9 OriGene Technologies
- 6.9.1 OriGene Technologies Company Information
- 6.9.2 OriGene Technologies Business Overview
- 6.9.3 OriGene Technologies Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 OriGene Technologies Gene Synthesis Software Product Portfolio
- 6.9.5 OriGene Technologies Recent Developments
- 6.10 Thermo Fisher Scientific
- 6.10.1 Thermo Fisher Scientific Company Information
- 6.10.2 Thermo Fisher Scientific Business Overview
- 6.10.3 Thermo Fisher Scientific Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Thermo Fisher Scientific Gene Synthesis Software Product Portfolio
- 6.10.5 Thermo Fisher Scientific Recent Developments
- 6.11 Bio Basic
- 6.11.1 Bio Basic Company Information
- 6.11.2 Bio Basic Business Overview
- 6.11.3 Bio Basic Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bio Basic Gene Synthesis Software Product Portfolio
- 6.11.5 Bio Basic Recent Developments
- 6.12 Twist Bioscience
- 6.12.1 Twist Bioscience Company Information
- 6.12.2 Twist Bioscience Business Overview
- 6.12.3 Twist Bioscience Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Twist Bioscience Gene Synthesis Software Product Portfolio
- 6.12.5 Twist Bioscience Recent Developments
- 6.13 BioCat GmbH
- 6.13.1 BioCat GmbH Company Information
- 6.13.2 BioCat GmbH Business Overview
- 6.13.3 BioCat GmbH Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 BioCat GmbH Gene Synthesis Software Product Portfolio
- 6.13.5 BioCat GmbH Recent Developments
- 6.14 ProteoGenix
- 6.14.1 ProteoGenix Company Information
- 6.14.2 ProteoGenix Business Overview
- 6.14.3 ProteoGenix Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 ProteoGenix Gene Synthesis Software Product Portfolio
- 6.14.5 ProteoGenix Recent Developments
- 6.15 Charles River
- 6.15.1 Charles River Company Information
- 6.15.2 Charles River Business Overview
- 6.15.3 Charles River Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Charles River Gene Synthesis Software Product Portfolio
- 6.15.5 Charles River Recent Developments
- 6.16 Biosearch Technologies
- 6.16.1 Biosearch Technologies Company Information
- 6.16.2 Biosearch Technologies Business Overview
- 6.16.3 Biosearch Technologies Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Biosearch Technologies Gene Synthesis Software Product Portfolio
- 6.16.5 Biosearch Technologies Recent Developments
- 6.17 Beijing SBS Genetech
- 6.17.1 Beijing SBS Genetech Company Information
- 6.17.2 Beijing SBS Genetech Business Overview
- 6.17.3 Beijing SBS Genetech Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Beijing SBS Genetech Gene Synthesis Software Product Portfolio
- 6.17.5 Beijing SBS Genetech Recent Developments
- 6.18 Eton Bioscience
- 6.18.1 Eton Bioscience Company Information
- 6.18.2 Eton Bioscience Business Overview
- 6.18.3 Eton Bioscience Gene Synthesis Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Eton Bioscience Gene Synthesis Software Product Portfolio
- 6.18.5 Eton Bioscience Recent Developments
7 North America
- 7.1 North America Gene Synthesis Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Gene Synthesis Software Market Size by Country (2021-2026)
- 7.3 North America Gene Synthesis Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Gene Synthesis Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Gene Synthesis Software Market Size by Country (2021-2026)
- 8.3 Europe Gene Synthesis Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Synthesis Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Gene Synthesis Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Gene Synthesis Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Gene Synthesis Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Gene Synthesis Software Market Size by Country (2021-2026)
- 10.3 South America Gene Synthesis Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Synthesis Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Gene Synthesis Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Gene Synthesis Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst